Arotech Corporation (ARTX)
(Delayed Data from NSDQ)
$2.89 USD
+0.02 (0.70%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.88 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.89 USD
+0.02 (0.70%)
Updated May 3, 2019 04:00 PM ET
After-Market: $2.88 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Arotech (ARTX) Q3 Earnings Match Estimates
by Zacks Equity Research
Arotech (ARTX) delivered earnings and revenue surprises of 0.00% and -10.87%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Arotech (ARTX) Reports Next Week: What to Expect
by Zacks Equity Research
Arotech (ARTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy Arotech (ARTX) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Arotech (ARTX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Arotech (ARTX) delivered earnings and revenue surprises of 200.00% and 7.82%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for May 17th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Arotech (ARTX) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Arotech (ARTX) delivered earnings and revenue surprises of -200.00% and -13.78%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Arotech (ARTX) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Arotech (ARTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arotech (ARTX) Catches Eye: Stock Jumps 7%
by Zacks Equity Research
Arotech (ARTX) saw a big move last session, as its shares jumped 7% on the day, amid huge volumes.
Arotech (ARTX) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Arotech (ARTX) delivered earnings and revenue surprises of 200.00% and 1.46%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Arotech (ARTX) Q3 Earnings Expected to Decline
by Zacks Equity Research
Arotech (ARTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arotech (ARTX) Matches Q2 Earnings Estimates
by Zacks Equity Research
Arotech (ARTX) delivered earnings and revenue surprises of 0.00% and -7.90%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for December 7th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
L3 Technologies Wins $49M Deal to Upgrade SATCOM Terminals
by Zacks Equity Research
L3 technologies' (LLL) Communications Systems segment offers airborne, space and surface data link terminals, ground stations, and transportable tactical SATCOM systems
Should You Add L3 Technologies (LLL)) to Your Portfolio?
by Zacks Equity Research
L3 Technologies (LLL) follows a disciplined divestment strategy to efficiently focus on its core operations. However, it faces strong competition from peers.
L3 Technologies Clinches Commercial Contracts Worth $115M
by Zacks Equity Research
Apart from exploiting its legacy defense business that includes unmanned systems equipment and secure communication systems, L3 Technologies (LLL) also holds a strong ground in the commercial aviation space.
L3 Technologies Wins $83M Deal for TH-57's Support Service
by Zacks Equity Research
Going ahead, L3 Technologies (LLL) expects to gradually transform its business portfolio to focus on defense electronics, communications and ISR markets.
FLIR Systems (FLIR) Reports In-Line Earnings in Q1, Sales Up
by Zacks Equity Research
FLIR Systems' (FLIR) first-quarter 2017 earnings were in line with estimates.
L3 Technologies' Acquisitions, Solid Cash Balance Impress
by Zacks Equity Research
In Jan 2017, L3 Technologies (LLL) completed the buyout of Implant Sciences' explosives trace detection (ETD) assets to increase its capabilities in the global aviation security
Arotech (ARTX) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Arotech Corporation (ARTX).
L3 Technologies Acquires ETD Assets of Implant Sciences
by Zacks Equity Research
L3 Technologies (LLL) completed the acquisition of Implant Sciences' explosives trace detection (ETD) assets.
FLIR Systems Unveils Thermal Camera Lineup at CES 2017
by Zacks Equity Research
FLIR Systems, Inc. (FLIR) recently unveiled a camera lineup at CES 2017, an eventful consumer electronics and technology trade show frequented by tech biggies to introduce latest offerings.
Arotech, Cooper Companies, UnitedHealth Group, Aetna and Humana highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Arotech, Cooper Companies, UnitedHealth Group, Aetna and Humana highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Arotech Corp (ARTX)
by Brian Bolan
This small cap is a perfect fit for investors looking for a "Trump Bump."
Has the Defense Industry Outlook Really Improved?
by Zacks Equity Research
Increasing threats, uncertainty and the rising need to safeguard the interest of nations and people have pushed up demand for weapons.
Zacks Investment Ideas feature highlights: Arotech, Braksem, BHP Billiton, Suncor Energy and Thor Industries
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Arotech, Braksem, BHP Billiton, Suncor Energy and Thor Industries